2.5 mg semaglutide 2 Semaglutide 2.5mg - Nuceria Health,
Description
The patient reported having an unremarkable magnetic resonance imaging (MRI) scan of the brain in the past
While semaglutide only targets and binds to GLP-1 receptors, tirzepatide is a dual agonist that acts on both GLP-1 and GIP receptors
The relative risk was 0.76, actually trending slightly lower than placebo, though not statistically significant
Hou S, Tang X, Cui H, et al
Semaglutide injections come in solution form and theres a greater risk of contamination, bacterial, or fungal growth in the solution when using the medication beyond its shelf life
